These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24132814)

  • 1. Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis.
    Gormsen LC; Christensen NL; Bendstrup E; Tolbod LP; Nielsen SS
    J Nucl Cardiol; 2013 Dec; 20(6):1108-15. PubMed ID: 24132814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Masuda A; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Hirata K; Nishimura M; Tamaki N
    J Nucl Cardiol; 2016 Apr; 23(2):244-52. PubMed ID: 26243179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
    J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis.
    Vidula MK; Selvaraj S; Rojulpote C; Bhattaru A; Kc W; Hansbury M; Schubert E; Clancy CB; Rossman M; Goldberg LR; Farwell M; Pryma D; Bravo PE
    Circ Cardiovasc Imaging; 2024 Aug; 17(8):e016774. PubMed ID: 39082134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
    Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
    Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
    Tang R; Wang JT; Wang L; Le K; Huang Y; Hickey AJ; Emmett L
    Clin Nucl Med; 2016 Jul; 41(7):e327-39. PubMed ID: 26646995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
    Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
    J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
    Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Furuya S; Naya M; Manabe O; Hirata K; Ohira H; Aikawa T; Koyanagawa K; Magota K; Tsujino I; Anzai T; Kuge Y; Oyama-Manabe N; Kudo K; Shiga T; Tamaki N
    J Nucl Cardiol; 2021 Oct; 28(5):2141-2148. PubMed ID: 31820409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart.
    Masuda A; Naya M; Manabe O; Magota K; Yoshinaga K; Tsutsui H; Tamaki N
    Acta Radiol; 2016 Jun; 57(6):661-8. PubMed ID: 26339041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.
    Scholtens AM; Verberne HJ; Budde RP; Lam MG
    J Nucl Med; 2016 Apr; 57(4):568-73. PubMed ID: 26659348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
    Demeure F; Hanin FX; Bol A; Vincent MF; Pouleur AC; Gerber B; Pasquet A; Jamar F; Vanoverschelde JL; Vancraeynest D
    J Nucl Med; 2014 Oct; 55(10):1629-35. PubMed ID: 25082852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium.
    Wiggers H; Nørrelund H; Nielsen SS; Andersen NH; Nielsen-Kudsk JE; Christiansen JS; Nielsen TT; Møller N; Bøtker HE
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H938-46. PubMed ID: 15805229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variances of dietary preparation for suppression of physiological
    Atterton-Evans V; Turner J; Vivanti A; Robertson T
    J Nucl Cardiol; 2020 Apr; 27(2):481-489. PubMed ID: 30088196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.